chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 18 year old male who on 10-FEB-1993 was vaccinated with a first dose of MMR II. On 14-NOV-1996 the patient was vaccinated with a second dose of MMR II. On 09-DEC-2009 the patient experienced mumps (thought the date diagnosed was reported as 11-NOV-2009). Other symptoms presented by the patient included dizziness. The patient was afebrile. ON 11-NOV-2009 the patient had a serum immunoglobulin M test, which came back negative, serum immunoglobulin G test: 4.66 and a serum amylase test: 195. The patient's outcome was unknown. Follow up information has been received regarding the 18 year old male patient who on 09-NOV-2009 (previously reported as 09-DEC-2009) experienced mumps. On 11-NOV-2009, the patient was diagnosed with mumps, the patient was afebrile and developed right parotitis. On 11-NOV-2009 the first blood work was performed, the results were: IgM (<1:10); <1:10, IgG (>1.10); 5.48 and serum amylase: 106. At the time of the report, the patient's outcome was unknown. No further information is available.
Patient presented to pharmacy to receive the COVID19 adult bivalent Moderna booster vaccine. The pharmacist preparing the vaccine drew up the incorrect vaccination, instead administering the pediatric monovalent Moderna vaccine to the patient. The patient reported that he experienced a sore arm following the vaccination that resolved on 12/05/22, but no other symptoms at this time. Patient did not have a primary care provider for followup, and upon discussion with the pharmacy manager agreed to return to pharmacy in 2 months after the time of the incorrect monovalent administration to receive the correct bivalent formulation.
Received MMR, DTAP and IPV immunizations.  Within 10 minutes, child complained of itchy, red palms, blotchy rash, nausea, vomited x2.  Patient complained of mouth felt "funny", "it hurt."  Within 30 minutes - skin red over entire body, lips slightly swollen.
Severe migraines starting around 36 hours after first vaccination. Arm was sore after 2-3 hours of shot. Missed work 1/2 day on Thursday 1/7/2021 because I woke up at 6am with worst headache I?ve had, took Tylenol & it eased off, went into work at my health Dept I work at. Thursday night 1/7, I had headaches so bad I couldn?t sit up, putting ice packs on my head made it worse, ears ringing, started throwing up with severe stomach pains at 11pm on 1/7/2021. Took excederin & Dramamine around 11am Friday 1/8/21, been alternating Tylenol & excederin with some improvement in headache. Slept most all of today 1/8/21 with my highest fever getting up to 100  degrees Fahrenheit on Friday 1/8/21 at 11am. Currently it?s at 98. Bad body aches & feeling uneasy/shaky the night of 1/7/21
Post vax, the pt experienced immediate pain at the injection site, pain in arm, metallic taste in mouth, headache, feeling sick all over and felt unsteady on feet.
Injection site extremely high on arm right below shoulder bone that comes out from clavicle. Injection time after insertion of needle was very long, about 10 seconds. Within an hour extreme pain, unable to use arm.
Headache congestion, fatigue, body aches Narrative:  patient took ibuprofen
Patient fainted a couple hours after vaccine. Last remembers calling work to say she couldn't come in, then woke up 2 hours later on the couch (same place she made the call). Felt woozy before fainting.
Site swollen, red, warm to touch, feeling nausea, diarrhea, body aches, fever.
MEDICATION ADMINISTERED AS AN "OFF-LABEL" USE DUE TO PATIENT AGE. PATIENT ONLY EXPERIENCED MUSCLE SORENESS IN INJECTION ARM.
pain; Every morning every day I wake up stiff as a lock; started having muscle spasms, and it has continued ever since the first dose / muscle spams in his back, upper shoulders, whole muscles, whole back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), MUSCULOSKELETAL STIFFNESS (Every morning every day I wake up stiff as a lock) and MUSCLE SPASMS (started having muscle spasms, and it has continued ever since the first dose / muscle spams in his back, upper shoulders, whole muscles, whole back) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concomitant products included DULOXETINE for Depression, GABAPENTIN for Sleep problem.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (pain), MUSCULOSKELETAL STIFFNESS (Every morning every day I wake up stiff as a lock) and MUSCLE SPASMS (started having muscle spasms, and it has continued ever since the first dose / muscle spams in his back, upper shoulders, whole muscles, whole back). At the time of the report, PAIN (pain), MUSCULOSKELETAL STIFFNESS (Every morning every day I wake up stiff as a lock) and MUSCLE SPASMS (started having muscle spasms, and it has continued ever since the first dose / muscle spams in his back, upper shoulders, whole muscles, whole back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient Stated that he has been going to all kind of doctors and physical therapists. No treatment was taken by the patient.   This case was linked to MOD-2021-253995 (Patient Link).
pt devel swelling @ inj site;pt exp pain;pt exp tenderness & swelling in lt arm @ inj site;, fever, palpitation;tender mass over lt deltoid;blood sugar 644;HCO 2 12;uncontrolled diabetes mellitus secondary to abscess;gen body pain;neck pain
10/19/05 high temperature 1 AM 103 degrees to 4 AM 99.2 AX 10/21/05 started on macrobid for UTI
1 week later presented with petechia to the left lower thigh and upper leg; pinpoint non-blanching lesions purple in color. No other sites of petechia or clinical bleeding. CBC was done and normal including platelet count of 489mm3. He returned to clinic 1 week later with nearly resolved rash.
Angioedema of the lips; Itching of the left arm; rash of the left forearm; This spontaneous case was reported by a physician and describes the occurrence of ANGIOEDEMA (Angioedema of the lips) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 04-Apr-2021, the patient experienced ANGIOEDEMA (Angioedema of the lips) (seriousness criterion medically significant), VACCINATION SITE PRURITUS (Itching of the left arm) and VACCINATION SITE RASH (rash of the left forearm). On 06-Apr-2021, ANGIOEDEMA (Angioedema of the lips), VACCINATION SITE PRURITUS (Itching of the left arm) and VACCINATION SITE RASH (rash of the left forearm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included the Oral Benadryl.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
PT PRESENTED WITH 1.5 INCH (PER PT) RED RAISED BUMP ON LEFT ARM. NO TREATMENT TO DATE.
Chills, Low-Grade fever initially, then 100.7 Fever the following day on 1/21/2017. Large induration at administration site, redness, pain, body aches.
Patient complains of pain in her left arm at the injection site since receiving her first dose of Gardasil on 10/7/2009.  She first reported this complaint to our office on 10/14/2009 and stated that the pain was worse with movement and she was experiencing difficulty using her left arm due to the discomfort, and she was advised to try ibuprofen and heat.  She returned to our office on 10/16/2009 for evaluation and reports that ibuprofen has not provided adequate relief and heat made the pain worse.  Upon examination, there is no erythema or swelling at the site and no tenderness to palpation.  There is full range of motion and normal grip and fine motor movement in both hands.  She was given a prescription for a non-steroidal anti-inflammatory medication and will follow up next week to report on her condition.
Patient has been experiencing pain at injection site for 3 months. Describes pain as "sensitive, sore, nerve-like pain" feels better with ibuprofen
Patient reports occasional dizziness upon movement which started approximately 2 days post-vaccination with first dose of Pfizer.  Dizziness has worsened progressively over 2 weeks.  She also experienced diarrhea about a week post-vaccination, but just for one day.  She seems to be most dizzy when moving in bed, describes as "room spinning".   She is now 2 weeks post-vaccination and symptoms have not improved.
Patient received the liquid portion only of shingrix without reconstitution; Received the liquid portion only; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number jn93x, expiry date 07-JUL-2024) for prophylaxis.   On 11-MAY-2023, the patient received Shingrix. On 11-MAY-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Patient received the liquid portion only of shingrix without reconstitution) and inappropriate dose of vaccine administered (Verbatim: Received the liquid portion only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 11-MAY-2023 The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow up. The patient received the liquid portion only of Shingrix without reconstitution, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Patient presents after developing itching and rash after Bivalent Booster.  Reports she has had primary and 1 booster of Pfizer.  States approximately 1 hour after administration she developed red rash to bilateral forearms and itching "all over."  States itching feels "inside of her body."  Reports she also had redness and swelling at injection site but that has resolved.    Continues to have rash and itchy sensation
Fever to 105 the noc pt recvd vax-resolved w/oral APAP;
Initial swelling at injection site, swelling and pain of left knee began on  4/3/21 with no known cause, slight raised red bump rash began on 4/23/21 on  arms and legs with no known cause, not itchy, after 2nd shot rash was exacerbated and spread to hands, back of shoulders and feet.  Swelling and joint pain of knees ankles and hips began within one day of second vaccination and became severe in left ankle and inner left knee by 4/29/21, then transitioned to severe pain and swelling in right ankle and inner knee a week later.  Rash persisting but still not itchy.
Swelling in left arm up to neck and swollen painful gland or "lump" in neck in same arm Tdap was given on 7/19/2011.
muscle fatigue; ears were ringing; This is a spontaneous report from a contactable female consumer (patient) reported for herself. A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8729) administered in upper left arm on 01Apr2021 as single dose for covid-19 immunisation. Medical history included heart murmur diagnosed when she was quite young as a child by pediatrician, overweight, and allergic to Penicillin. The patient's concomitant medications were not reported. None other vaccines administered on same date. On 01Apr2021 mid afternoon after patient got the shot, her ears were ringing and was worse the next day and was more pronounced, it is not going away. On the second day 02Apr2021, she started to notice the muscle fatigue, her strength back until 04Apr2021. The outcome of ear ringing was not recovered, of muscle fatigue was recovering.  No follow-up attempts are needed. No further information is expected.
The dayi got vaccinated was my last  cycle day but now it has been two weeks and my period still has not stopped.
Customer received vaccination. Initially, said she was fine receiving vaccinations in the past with only one incidence where she fainted/needed medical attention. After consulting the patient, she felt confident she can still receive her vaccine based on her history. Within seconds after receiving the vaccine, the patient stated she felt like fainting. I responded by holding her upright as she began to fall an then she began to have seizure-like symptoms followed by being guided to the floor (as she was falling off the edge of the chair) and then subsequently urinating. Within seconds, the patient regained consciousness and was checked for alertness and orientation (by verifying name, location, and what was happening). They were asked if they would like for an ambulance/emergency services to be called to which she declined. They were further counseled to assess for other signs/symptoms but only reported a pain in her foot as she put pressure on it while being guided off the chair to the floor. This pain resolved in minutes. She was subsequently picked up by her significant other and then proceeded to wait for the recommended 30 minutes after receiving a vaccine. During this time she was continually monitored by me for changes in cognitive function and further signs and symptoms. Patient was ambulatory at end of incidence and showed no further signs and symptoms of cognitive impairment, seizures, or any other conditions that may have required medical attention.
EMPLOYEE STATED HE HAD CHILLS AND SOME MUSCLE ACHES DURING THE NIGHT BUT WOKE UP FEELING VERY WELL
COVID 19 Treatment; COVID 19 Treatment; Vaccine brand other: Moderna,Vaccine administration date: 19Aug2022; Vaccine brand: Pfizer / BioNTech, Vaccine administration date: 27Oct2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 58-year-old male patient received BNT162b2 (BNT162B2), on 27Oct2021 as dose 3 (booster), single (Lot number: 320308D) at the age of 57 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 19Aug2022 as dose 4 (booster), single (Lot number: 053B22A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing), notes: other medical history: Celiac Sprue. There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 19Aug2022, outcome "not recovered", described as "Vaccine brand other: Moderna,Vaccine administration date: 19Aug2022; Vaccine brand: Pfizer / BioNTech, Vaccine administration date: 27Oct2021"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Nov2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Oct2022) Negative; (01Nov2022) Positive; (unspecified date) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that, other medication in 2weeks was No. It was reported that, the patient was tested positive again 01Nov2022 after negative test 26Oct2022. Symptoms worse-sinus and chest infection. No known allergies.
INJECTION SITE REACTION, BUT MULTIPLE PATIENTS WITH INJECTION SITE REACTIONS AT VARIOUS FACILITIES, WITH FLUZONE QUAD AND FLUZONE HD.  VARIOUS AGES. NO REACTION LAST YEAR, BUT REDNESS @ INJECTION SITE THIS YEAR.........................
High heart rate for most of the day; Body aches; Running nose; sneezing; eye infection; rash on face and swollen; rash on face and swollen; This is a spontaneous report from a contactable Consumer (patient). A 56-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 at 13:00 (at the age of 56-years-old) as a dose 1, single for COVID-19 immunisation. Patient's medical history included seasonal allergy, mycotic allergy (mold), drug hypersensitivity to Penicillin and food allergy to wheat, all were from an unknown date and unknown if ongoing. Concomitant medications received within 2 weeks were not specified. Patient received Allergy shot (Other vaccine) on Left arm within 4 weeks on 01Mar2021. Patient did not have covid prior vaccination. On 03Mar2021 at 13:00, the patient experienced High heart rate for most of the day. Body aches, running nose, sneezing and then had an eye infection, rash on face and swollen that lasted for several days. On 09Mar2021 doing better but not fully recovered. Patient did not have any treatment for the events. He had been tested for covid post vaccination. The patient underwent lab tests and procedures which included heart rate: high, on 03Mar2021 and sars-cov-2 test (Nasal Swab) with unknown result, on 01Mar2021. The outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
Swelling to my lower body; Some pain; Itching; Diarrhea; Vomiting; Body sweats; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0169, Expiration date not reported), via an unspecified route of administration, administered in arm right on 30Jun2021 at 13:00 (at the age of 47-year-old) as single dose for COVID-19 immunisation. Family medical history included colon cancer (Verbatim: mother colon cancer), cataract, high blood pressure and diabetes mellitus (Verbatim: Grandmother cataracts, high blood pressure, diabetes). The patient's medical history and concomitant medications were reported as none. Prior vaccinations were reported as none. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0202, Expiration date not reported), via an unspecified route of administration, administered in arm left on 09Jun2021 at 08:30 (at the age of 47-year-old) as single dose for COVID-19 immunisation and experienced from bottom of my knees all down its swollen. On an unspecified date, the consumer reported that she had a lot of swelling to her lower body, some pain, Itching, diarrhea, vomiting, body sweats, but all of this was after she took the Vaccine shots. Relevant tests were reported as none. The reporter classified the events as non-serious. The outcome of the events was unknown.
Breakthrough Covid; Breakthrough Covid; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration in left arm on 16Feb2021 at 12:00 PM (at the age of 70 years old, not pregnant at the time of vaccination) as dose 2, single and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: F69263), via an unspecified route of administration in left arm on 26Jan2021 on 12:00 PM (at the age of 69 years old) for covid-19 immunisation. Medical history included heart disease (stent in LAD in Sep2018), stent placement from Sep2018 to an unknown date. The patient had known allergies to statins. Concomitant medications in two weeks included alirocumab (PRALUENT). The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 08Aug2021 at 10:00 AM patient experienced breakthrough covid. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab): positive on 09Aug2021. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not received treatment due to the events. The outcome of events was recovered on an unspecified date in 2021.
STABLE ANGINA 3/11/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
father brought child into facility stated child had a rxn to vax given on 25MAR98 blister reddened rash surrounding upper & lower lips, small streak of same rash noted on lt cheek & rt ear;
Lost complete use of my legs and partial use of my arms. Unable to walk. Spiral fracture of left ankle upon dropping to the floor when losing the use of my legs.
My wife had a stroke.  She went to the doctor on 1-3 complaining of severe headaches and vision issues, they thought it was covid. She was tested next day for covid and it was negative.  on 1-6 i took her to the ER and she was diagnosed with a stroke at the hospital.  She is still have lingering eye issues, and the attending physicians are stating the vision issues are not from the stroke, as the area impacted was the Cerrebellum which only impacts balance.  My wife has permanent brain damage from this issue.   She is home and doing well, but in no way is this coincidental.  this was brought on by these vaccines.  she is healthy with zero health issues, and all heart and other test were good.